Clinical Trials Directory

Trials / Unknown

UnknownNCT01618110

Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders

Transcranial Magnetic Stimulation of the Pre-Frontal Cortex in the Treatment of Attention Deficit/Hyperactivity Disorders: A Randomized, Controlled, Double Blind Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Shalvata Mental Health Center · Academic / Other
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

* ADHD is one of the most common psychiatric disorders. * While most of the attention is directed towards youth, 60% continue to suffer symptoms into adult life. * Current treatment is effective, but 30% suffer side effects that lowers QOL, and 20% are non-responders. * Known mechanism of pathophysiology includes hypoactive dopaminergic system, especially at right PFC. * It is this study hypothesis that by stimulating the right PFC by TMS, it will be possible to alleviate ADHD symptoms. * A 10 sessions of treatment will by applied on a randomly allocated group of patients, diagnosed with ADHD, in a 2:1 ratio: The first group will receive an actual TMS treatment, and the second group will receive a sham treatment. * Improvement of objective and subjective ADHD scale will be examined.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Magnetic Stimulation (Magstim, Rapid)Superficial rTMS, directed at right PFC, power of 100% of MT, 10Hz for 4 seconds, intervals of 30 seconds, 42 trains.
OTHERPlacebo TreatmentSham coil (minimal magnetic field, same noise and feeling)

Timeline

Start date
2012-07-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2012-06-13
Last updated
2012-06-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01618110. Inclusion in this directory is not an endorsement.